Impact of cross-reference pricing on pharmaceutical prices: manufacturers' pricing strategies and price regulation.

abstract：BACKGROUND:Hepatocellular carcinoma (HCC) is the second most common cancer in Taiwan. For males in Taiwan, it is the most dangerous cancer, with both the highest incidence and mortality rate. OBJECTIVE:To determine cancer-related medical care costs for long-term survivors of HCC. METHODS:The estimation of the lifetim...

journal_title：Applied health economics and health policy

authors： Lang HC,Wu JC,Yen SH,Lan CF,Wu SL

更新日期：2008-01-01 00:00:00

abstract：BACKGROUND:Canadian patients, healthcare providers and payers share interest in assessing the value of self-monitoring of blood glucose (SMBG) for individuals with type 2 diabetes but not on insulin. Using the UKPDS (UK Prospective Diabetes Study) model, the Canadian Optimal Prescribing and Utilization Service (COMPUS)...

journal_title：Applied health economics and health policy

authors： Tunis SL

更新日期：2011-11-01 00:00:00

abstract：BACKGROUND:Immunization rates for human papillomavirus (HPV) infections remain low among teenagers despite strong evidence of the effectiveness of vaccines. Physician recommendations of the vaccine are far from universal. Several states have enacted policies that mandate HPV vaccination or distribute educational materi...

journal_title：Applied health economics and health policy

authors： Moghtaderi A,Adams S

更新日期：2016-06-01 00:00:00

abstract：INTRODUCTION:From 2000 to 2004, primary care organisations (PCOs) in England were legally required to operate a prescribing incentive scheme for their general practices. A statutory framework specified the types of target, maximum rewards and use of 'good cause for failure' provisions that schemes should include. Our o...

journal_title：Applied health economics and health policy

authors： Mason AR,Drummond MF,Hunter JA,Towse AK,Cooke J

更新日期：2005-01-01 00:00:00

abstract：BACKGROUND:Chronic obstructive pulmonary disease (COPD) affects approximately 3 million people in the UK. An 8-week pulmonary rehabilitation (PR) course is recommended under current guidelines. However, studies show that initial benefits diminish over time. OBJECTIVE:We present here an economic evaluation conducted al...

journal_title：Applied health economics and health policy

authors： Burns DK,Wilson EC,Browne P,Olive S,Clark A,Galey P,Dix E,Woodhouse H,Robinson S,Wilson A

更新日期：2016-02-01 00:00:00

abstract：:Smoking is an expensive habit. Smoking households spend, on average, more than $US1000 annually on cigarettes. When a family member quits, in addition to the former smoker's improved long-term health, families benefit because savings from reduced cigarette expenditures can be allocated to other goods. For households i...

journal_title：Applied health economics and health policy

authors： Busch SH,Jofre-Bonet M,Falba TA,Sindelar JL

更新日期：2004-01-01 00:00:00

abstract：:There is wide consensus that the ways in which providers are reimbursed by third parties will affect their behaviour and, hence, the efficient use of limited resources and the performance of health systems. However, there seems to be little evidence on how payment to hospital-based doctors affects hospital performance...

journal_title：Applied health economics and health policy

authors： Liu X,Mills A

更新日期：2003-01-01 00:00:00

abstract：BACKGROUND:Decision makers within the Calgary Health Region adopted and applied programme budgeting and marginal analysis (PBMA) for priority-setting activity across major service portfolios within the Region. METHODS:Seventeen in-depth qualitative interviews were conducted with senior managers and clinicians to gain ...

journal_title：Applied health economics and health policy

authors： Mitton C,Patten S,Donaldson C

更新日期：2004-01-01 00:00:00

abstract：BACKGROUND:South Korea is unique in that it leads global markets in R&D as well as production of biosimilar products and was the first market into which some biosimilar products were introduced. We analyzed the time trend of market penetration and simulated saved spending by biosimilars in South Korea. METHODS:We pull...

journal_title：Applied health economics and health policy

authors： Lee HJ,Han E,Kim H

更新日期：2020-08-01 00:00:00

abstract：:A routine part of the process for developing National Institute for Health and Care Excellence (NICE) medical technologies guidance is a submission of clinical and economic evidence by the technology manufacturer. The Birmingham and Brunel Consortium External Assessment Centre (EAC; a consortium of the University of B...

journal_title：Applied health economics and health policy

authors： Higgins A,Glover M,Yang Y,Bayliss S,Meads C,Lord J

更新日期：2014-10-01 00:00:00

abstract：:This article deals with the accuracy of statistical records used for political decision making and international comparative analysis. In developing countries, even major macroeconomic indicators can include data inadequacies and methodological differences in data generation between statistical agencies. Existing data...

journal_title：Applied health economics and health policy

authors： Lorenz C

更新日期：2012-01-01 00:00:00

abstract：:The biotech industry now accounts for a substantial and growing proportion of total R&D spending on new medicines. However, compared with the pharmaceutical industry, the biotech industry is financially fragile. This article illustrates the financial fragility of the biotech and pharmaceutical industries in the US and...

journal_title：Applied health economics and health policy

authors： Golec J,Vernon JA

更新日期：2009-01-01 00:00:00

abstract：:Despite recent initiatives across a number of countries to institutionalise the use of economic evaluation in the assessment of new technologies, the evidence suggests that, to date, the impact of economic analysis on health sector decision making in practice has been low. This paper proposes that incentive compatibil...

journal_title：Applied health economics and health policy

authors： Jan S

更新日期：2003-01-01 00:00:00

abstract：:Economic models are developed to provide decision makers with information related to the real-world effectiveness of therapeutics, screening and diagnostic regimens. Although compliance with these regimens often has a significant impact on real-world clinical outcomes and costs, compliance and persistence have histori...

journal_title：Applied health economics and health policy

authors： Kadambi A,Leipold RJ,Kansal AR,Sorensen S,Getsios D

更新日期：2012-11-01 00:00:00

abstract：BACKGROUND:It is estimated that annually 300 000 cases of rotavirus-induced gastroenteritis (RVGE) occur in children aged up to 5 years in France. A two-dose vaccine against rotavirus infection (RIX4414; Rotarix, GlaxoSmithKline), has been shown to be highly effective against severe RVGE. OBJECTIVE:This study evaluate...

journal_title：Applied health economics and health policy

authors： Standaert B,Parez N,Tehard B,Colin X,Detournay B

更新日期：2008-01-01 00:00:00

abstract：:This paper examines the use of propensity score matching in economic analyses of observational data. Several excellent papers have previously reviewed practical aspects of propensity score estimation and other aspects of the propensity score literature. The purpose of this paper is to compare the conceptual foundation...

journal_title：Applied health economics and health policy

authors： Crown WH

更新日期：2014-02-01 00:00:00

abstract：:In Germany, the Institute for Quality and Efficiency in Health Care (IQWiG) makes recommendations for ceiling prices of drugs based on an evaluation of the relationship between costs and effectiveness. To set ceiling prices, IQWiG uses the following decision rule: the incremental cost-effectiveness ratio (ICER) of a n...

journal_title：Applied health economics and health policy

authors： Gandjour A

更新日期：2011-03-01 00:00:00

abstract：BACKGROUND:Community-based health insurance (CBHI) schemes have been introduced in low- and middle-income countries to increase health service utilization and provide financial protection from high healthcare expenditures. OBJECTIVE:We assess the impact of household size on decisions to enroll in CBHI and demonstrate ...

journal_title：Applied health economics and health policy

authors： Ozawa S,Grewal S,Bridges JF

更新日期：2016-04-01 00:00:00

abstract：BACKGROUND:There is limited understanding of the health economic implications of cervical screening with human papillomavirus (HPV)-16/18 genotyping. OBJECTIVE:The aim of this study was to evaluate the cost effectiveness of cervical cancer primary screening with a HPV-16/18 genotyping test which simultaneously detects...

journal_title：Applied health economics and health policy

authors： Huh WK,Williams E,Huang J,Bramley T,Poulios N

更新日期：2015-02-01 00:00:00

abstract：:We conducted a scoping review with the objective of synthesizing available literature and mapping what designs and methods have been used to evaluate health insurance reforms in sub-Saharan Africa. We systematically searched for scientific and grey literature in English and French published between 1980 and 2017 using...

journal_title：Applied health economics and health policy

authors： Degroote S,Ridde V,De Allegri M

更新日期：2020-12-01 00:00:00

abstract：BACKGROUND:Osteoporosis is recognized as a serious health condition in developed as well as developing countries. There are no accurate estimates of the extent of the burden of osteoporosis in New Zealand. The purpose of this study was to estimate the economic burden of osteoporosis in New Zealand using data from inter...

journal_title：Applied health economics and health policy

authors： Brown P,McNeill R,Leung W,Radwan E,Willingale J

更新日期：2011-03-01 00:00:00

abstract：BACKGROUND:Early awareness and alert systems have been established in many countries but evidence on their ability to accurately prioritize new medicines (for early assessment) is limited. OBJECTIVE:The purpose of this study was to assess whether the Swedish Early Awareness and Alert System identified and prioritized ...

journal_title：Applied health economics and health policy

authors： Eriksson I,von Euler M,Malmström RE,Godman B,Wettermark B

更新日期：2019-02-01 00:00:00

abstract：BACKGROUND:Liposomal amphotericin B (L-AMB) and amphotericin B lipid complex (ABLC) are both indicated for treating invasive fungal infections (IFIs) caused by Aspergillus, Candida and Cryptococcus spp. among patients who are refractory to or intolerant of conventional amphotericin B (CAB). Prior studies have suggested...

journal_title：Applied health economics and health policy

authors： Yang H,Chaudhari P,Zhou ZY,Wu EQ,Patel C,Horn DL

更新日期：2014-02-01 00:00:00

abstract：:Smoking of tobacco products is a major public health challenge in prison settings in most countries. Although tobacco use was tolerated by custodial authorities for many decades, the overwhelming evidence of the adverse public health effects of tobacco on both the smokers and those in the vicinity of exhaled or passiv...

journal_title：Applied health economics and health policy

authors： Awofeso N

更新日期：2002-01-01 00:00:00

abstract：BACKGROUND:Although the costs of treating inflammatory bowel disease (IBD) in developed countries are well established, they remain largely unknown in countries with recent histories of socio-economic transition including Serbia. OBJECTIVE:To estimate the costs of treatment including the resources used by patients wit...

journal_title：Applied health economics and health policy

authors： Kostić M,Djakovic L,Šujić R,Godman B,Janković SM

更新日期：2017-02-01 00:00:00

abstract：OBJECTIVES:To analyse the cost effectiveness of community-based case management for patients suffering from chronic obstructive pulmonary disease (COPD). METHODS:The study took place in the third largest municipality in Denmark and was conducted as a randomised controlled trial with 12 months of follow-up. A total of ...

journal_title：Applied health economics and health policy

authors： Sørensen SS,Pedersen KM,Weinreich UM,Ehlers L

更新日期：2017-06-01 00:00:00

abstract：BACKGROUND:Costs of chronic wound care are significant, but systematic reviews of cost-effectiveness studies regarding guideline-based or strategic interventions are scarce. OBJECTIVES:Our objectives were to assess/compare the cost effectiveness of new interventions/systems designed to improve the prevention/treatment...

journal_title：Applied health economics and health policy

authors： Carter MJ

更新日期：2014-08-01 00:00:00

abstract：:One focus of health economics is the trade-off between limited resources and the (health) needs of a community. Cost-effectiveness analysis (CEA), while being one of the most accepted evaluation methodologies in health economics, does not account for many important costs and benefits of health care interventions. Some...

journal_title：Applied health economics and health policy

authors： Bridges JF

更新日期：2003-01-01 00:00:00

abstract：OBJECTIVE:Compared to traditional drugs, specialty drugs tend to be indicated for lower prevalence diseases. Our objective was to compare the potential population health benefits associated with specialty and traditional drugs in the year following product approval. METHODS:First, we created a dataset of estimates of ...

journal_title：Applied health economics and health policy

authors： Chambers JD,Thorat T,Wilkinson CL,Salem M,Subedi P,Kamal-Bahl SJ,Neumann PJ

更新日期：2017-04-01 00:00:00

abstract：BACKGROUND:Pricing drugs in the California Workers' Compensation System (CAWCS) has become more difficult as there are increasingly fewer drugs listed in the Medi-Cal primary fee schedule, which is used as the source for CAWCS drug prices. This presents a challenge of providing timely and accurate CAWCS reimbursement. ...

journal_title：Applied health economics and health policy

authors： Wilson L,Turkistani F,Tran DM,Huang W,Lin TK

更新日期：2019-04-01 00:00:00